LDLR and atherosclerosis: Control HFD mice had no lesions, whereas all rAAV8-PCSK9D377Y-injected mice on HFD (HCi HFD group) developed atherosclerosis to a similar extent as LDLR KO mice on HFD after 12 weeks and with no significant difference after 20 weeks (Figures 2A–I).